Clincosm LogoSign in Get a demo

FRENCH ICU: Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France

Sponsor
Centre Hospitalier Universitaire de Nīmes (Other)
Overall Status
Completed
CT.gov ID
NCT04420286
Collaborator
(none)
9,860
Enrollment
1
Location
1.2
Actual Duration (Months)
8111.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

For preventing the overwhelming of ICU beds capacity during COVID-19 pandemic in France, national and regional Health-Care institutions decided to optimize the Intensive Care Unit beds availability by opening new ICU beds in institutions with and without prior ICU. The Present study was design to retrospectively describe the origin of the ICU beds and human resources created during the COVID-19 outbreak in France.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Since December 2019, the SARS-CoV-2 coronavirus disease has caused a worldwide outbreak of respiratory illness that rapidly invaded leading the world (WHO). Its most severe form is dominated by an acute respiratory distress syndrome (ARDS) with other organ failures requiring mechanical ventilation and admission in Intensive Care Unit (ICU). With a wide pandemic effect and a long length of mechanical ventilation, the intensive care units were quickly full.

    For preventing the overwhelming of ICU beds capacity, national and regional Health-Care institutions (then French Health minister, every Regional Health) decided to optimize the Intensive Care Unit beds availability by opening new ICU beds in institutions with and without prior ICU.

    Daily ICU beds availability was assessed in each institution, and at the regional level to organize potential patient transfers across regional and national hospital. Moreover, an extraordinary mobilization and joint efforts of medical, paramedical and administrative staff allowed getting the caregivers for managing the most severe patients in each ICU. All physicians who could manage ICU patients were involved in this crisis. In this context, anesthesiologists (who have gotten an ICU education during their studies) were involved, as the surgical activity has been reduced to the vital procedures. This overall organization permitted the admission of more patients than the initial maximum national capacity of ICU beds.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    9860 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Study of the Increase in ICU Beds Capacity and Caregivers During COVID-19 Pandemic in France : the FRENCH ICU Study
    Actual Study Start Date :
    May 6, 2020
    Actual Primary Completion Date :
    Jun 12, 2020
    Actual Study Completion Date :
    Jun 12, 2020

    Arms and Interventions

    Arm Intervention/Treatment
    Hospital having ICU beds

    Hospital having ICU beds during COVID-19 outbreak in France

    Outcome Measures

    Primary Outcome Measures

    1. origin of the ICU beds created during the COVID-19 outbreak in France. [DAY 0]

      Describe the origin of the ICU beds created during the COVID-19 outbreak in France.

    Secondary Outcome Measures

    1. Human Resources [DAY 0]

      Describe the human resources (medical and non-medical) mobilized to ensure that all acute patients could be managed (physicians according to their initial specialty, nurses and nursing auxiliaries).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Hospital having ICU during COVID-19 outbreak in France
    Exclusion Criteria:
    • Hospital refuse to participate

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHU de Nîmes, Hôpital Universitaire Carémeau Nimes France 30029

    Sponsors and Collaborators

    • Centre Hospitalier Universitaire de Nīmes

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier Universitaire de Nīmes
    ClinicalTrials.gov Identifier:
    NCT04420286
    Other Study ID Numbers:
    • 30RC20_0117
    First Posted:
    Jun 9, 2020
    Last Update Posted:
    Aug 17, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Centre Hospitalier Universitaire de Nīmes
    COVID-19
    Critical care
    Intensive Care
    Additional relevant MeSH terms:
    COVID-19
    Coronavirus Infections

    Study Results

    No Results Posted as of Aug 17, 2021